Welcome to our dedicated page for Albemarle SEC filings (Ticker: ALB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating lithium volume forecasts or bromine pricing clauses in Albemarle’s 250-page reports can feel overwhelming. Stock Titan solves this by turning Albemarle’s complex SEC filings into clear, actionable insight—so you can focus on decisions, not document hunts.
Every filing is here in real time, from the Albemarle annual report 10-K simplified to the latest Albemarle quarterly earnings report 10-Q filing. Our AI surfaces segment-level EBITDA, capex plans for Chilean brine assets, and risk factors tied to lithium prices—without scrolling through footnotes. Need to monitor management moves? Receive instant alerts on Albemarle insider trading Form 4 transactions and track Albemarle Form 4 insider transactions real-time to spot buying or selling patterns ahead of material events.
Common questions are answered in-line: “How do I understand Albemarle SEC documents with AI?” Simply open any 8-K; our summary explains the supply-contract or environmental update in plain English. Curious about leadership pay? The Albemarle proxy statement executive compensation section highlights equity awards and performance metrics. Need context on sudden news? The platform links each Albemarle 8-K material events explained summary to prior disclosures, giving you timeline clarity in seconds.
Whether you’re reviewing catalysts margins, tracking debt covenants, or comparing Albemarle earnings report filing analysis across quarters, Stock Titan provides:
- AI-powered summaries that explain every form in simple terms
- Real-time EDGAR updates across 10-K, 10-Q, 8-K, S-8, and more
- Instant access to Albemarle executive stock transactions Form 4
- Downloadable data tables for quick model inputs
Spend less time parsing disclosures and more time understanding how Albemarle converts critical resources into shareholder value.
Initial Form 3 filing by Autumn M. Gagarinas for Albemarle Corporation (ALB). The report shows direct beneficial ownership of 4,054 common shares and disclosure of restricted stock units and stock options. Total RSUs disclosed vest between 2026 and 2028 and two option grants exercisable in 2027 and 2028 with expiration in 2034 and 2035. Ownership is reported in the filer\'s capacity as Chief People Officer.
Capital Research Global Investors filed a Schedule 13G reporting beneficial ownership of 6,307,813 shares of Albemarle Corporation common stock, representing 5.3% of the 119,818,504 shares believed outstanding as of the reporting event date. The filing notes that reported holdings include 4,721,204 Convertible Preferred Stocks, which the filer states represent 2,157,590 common shares.
The submission identifies CRGI as an investment management division and includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing is signed by Jae Won Chung on 08/05/2025 and lists issuer and filer addresses.
Albemarle Corporation announced an organizational change in which Netha N. Johnson, the company's Chief Operations Officer, left effective August 10, 2025, and Mark M. Mummert succeeded her as Chief Operations Officer effective August 11, 2025. Mr. Mummert joined Albemarle in 2019, has led the Energy Storage operating unit and capital projects, and brings prior supply chain and manufacturing experience from FMC, Rohm and Haas, and Dow.
The company disclosed Mr. Mummert's material compensation terms: an annual base salary of $550,000, continued participation in the annual incentive plan at a target of 80% of eligible earnings, a 2026 long-term incentive award with a $1,400,000 target value to be granted in Q1 2026, and standard executive benefits eligibility.
Krupa Ander C., identified as an officer (General Counsel & Secretary), reported an insider acquisition in Albemarle Corp (ALB) on 08/06/2025. The Form 4 shows an award of 7,430 restricted stock units (RSUs) granted at a $0 price and reported under transaction code A (acquisition).
The RSUs are described to vest 100% on August 6, 2028 per the award agreement. Following the reported grant the filing shows 11,771 shares beneficially owned by the reporting person. The form is signed by an attorney-in-fact on 08/08/2025.
Krupa Ander C., General Counsel & Secretary of Albemarle Corporation, reported beneficial ownership of 4,341 common shares, consisting of 1,560 issued shares and 2,781 restricted stock units granted across 2023–2025 with staggered vesting through 2028. She also disclosed 2,676 stock options: 1,608 exercisable 02/27/2028 (exp. 02/26/2035) at $78.97 and 1,068 exercisable 02/22/2027 (exp. 02/21/2034) at $118.18. All holdings and vesting terms are reported on Form 3.
Franklin Resources, Inc. and several affiliated investment managers filed Amendment No. 1 to Schedule 13G reporting passive ownership of Albemarle Corporation (ALB) common stock as of 30 June 2025.
The group reports 9,722,191 shares beneficially owned, equal to 8.0 % of ALB’s outstanding shares. Franklin Advisers, Inc. accounts for 8,422,920 shares, including 3,887,547 shares issuable upon debt conversion. Sole voting power covers 9,332,953 shares and sole dispositive power 9,659,698 shares; 62,493 shares are subject to shared voting/disposition, primarily by Templeton Asset Management Ltd.
The filing, made under Rule 13d-1(b), states the holdings are in the ordinary course of business and not intended to influence control. Major individual shareholders Charles B. Johnson and Rupert H. Johnson, Jr. report zero direct ownership. Franklin Income Fund, an advised client, holds 6,475,850 shares (5.3 % of the class). No change-of-control plans, material transactions, or additional events are disclosed.
FAQ
What is the current stock price of Albemarle (ALB)?
What is the market cap of Albemarle (ALB)?
